Novartis’ results show the firm humming along nicely in 2024, with sales driven by continued strong performance from its ...

Q4 2024 Earnings Call Transcript January 31, 2025 Novartis AG beats earnings expectations. Reported EPS is $1.98, ...

Good morning and good afternoon, and welcome to the Novartis Q4 2024 results release conference call and live webcast.

Good morning and good afternoon, and welcome to the Novartis Q4 2024 Results Release ... Now, moving to Slide 8. Kesimpta grew 49%, reaching $3.2 billion on the full year. It was outpacing both ...

Welcome to the Novartis presentation at the 43rd JPMorgan ... When you look at why we have that conviction, a lot of it is around our commercial execution. We have some of the leaders here in ...

Novartis (NOVN.S), opens new tab on Friday posted adjusted net income well above analyst estimates as sales of established heart failure drug Entresto and newer multiple sclerosis drug Kesimpta ...

Hailee Steinfeld and Wanda Sykes team up with pharmaceutical company Novartis to raise breast cancer awareness.

Novartis shares jumped 3.6% to a three-month high of 97.15 francs at 0941 GMT, with investors also encouraged by the company's upbeat 2025 earnings projections. Entresto, which will lose patent ...

The Super Bowl tackled breast cancer awareness in a new Novartis Commercial featuring survivor and comedian Wanda Sykes.

Last week, Swiss pharma giant Novartis NVS reported better-than-expected ... driven by the momentum in its key drugs like Entresto, Kesimpta, Kisqali, Cosentyx and Leqvio. Investors were impressed ...